Highlights Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 23/06/2024 BST			5-day change	1st Jan Change
11.16 ^CNY	-2.79%		-8.82%	-52.53%

06:09am	Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology	MT
06-18	Walvax Terminates Coronavirus Vaccine Trials Due to Mutations	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology	05:09am	MT
Walvax Biotechnology Co., Ltd. Implements Final Cash Dividend for the Year 2023, Payable on 30 May 2024	05-22	CI
Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024	04-26	MT
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
China's drugmakers can't sell mRNA shots but haven't quit yet	04-19	RE
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	04-03	CI
Walvax Biotechnology Co., Ltd.'s Equity Buyback announced on April 5, 2023, has expired with 2,000,000 shares, representing 0.12% for CNY 72.2 million.	04-02	CI
Walvax Biotechnology's 2023 Profit Falls 42%	04-02	MT
Walvax Biotechnology Co., Ltd. Proposes Cash Profit Distribution for 2023	04-01	CI
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit	01-26	MT
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	01-11	MT
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	01-03	CI
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Walvax Biotechnology's Unit Gets License to Market Pneumonia Vaccine in Indonesia; Shares Up 3%	24/10/23	MT
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	11/10/23	CI
Walvax Biotechnology Unit Gets Nod to Carry Out Vaccine's Phase III Trial in Indonesia	20/09/23	MT
Walvax Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23	CI
Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.	03/07/23	CI
Walvax Biotechnology Chairman, Affiliates Complete Purchase of 101 Million Yuan Shares	26/06/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Walvax Biotechnology Co., Ltd.

Equities

300142

CNE100000WN2

Highlights

Filters